Abstract
In this paper, BV-2 mouse small glial cell inflammation model induced by LPS is established. The experiment used 0.1-10 μM of telmisartan and Tek-1 to incubate with small glial cell and used telmisartan and Tek-1 to incubate with PPAR gamma special heterosexual antagonistic anti-agent GW9662. The article used ELISA method to dectect TNF-a effect on small glial cell for telmisartan and Tek-1. The article used real-time quantitative PCR method to dectect mRNA level expression effect of CD11b, CD16 and iNOS on small glial cell for telmisartan and Tek-1 and used Western Blot method to dectect MAPKs signal pathway and NF-κb signal turned guide pathway effect on small glial cell for telmisartan and Tek-1. Results show that Tek-1 had high affinity with AT1 receptor and inhibited intracellular calcium ion activation which can be for the AT1 receptor antagonists. Meanwhile, Tek-1 can partially activate PPAR gamma compared with full agonists of rosiglitazone.
References
[1] Cameron B., Landreth G.E., Inflammation, microglia, and Alzheimer’s disease, Neurobiol Dis., 2010, 37(3), 503-50910.1016/j.nbd.2009.10.006Search in Google Scholar PubMed PubMed Central
[2] Lue L.F., et al., Microglia activation and anti-inflammatory regulation in Alzheimer’s disease, Mol. Neurobiol., 2010, 41(2-3), 115-12810.1007/s12035-010-8106-8Search in Google Scholar PubMed PubMed Central
[3] Joglar B., Rodriguez-Pallares J., et al., The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease, J. Neurochem., 2009, 109, 656-66910.1111/j.1471-4159.2009.05999.xSearch in Google Scholar PubMed
[4] Lu Q., Zhu Y.Z., et al., Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats, Neuroreport, 2005, 16, 1963-196710.1097/01.wnr.0000187636.13147.cdSearch in Google Scholar PubMed
[5] Jung W.K., et al., Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases, Br. J. Pharmacol., 2010, 159(6), 1274-128510.1111/j.1476-5381.2009.00615.xSearch in Google Scholar PubMed PubMed Central
[6] Nagai Y., Akashi S., et al., Essential role of MD-2 in LPS responsiveness and TLR4 distribution, Nat. Immunol., 2002, 3(7), 667-67210.1038/ni809Search in Google Scholar PubMed
[7] Storer P.D., et al., Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis, J. Neuroimmunol., 2005, 161(1-2), 113-12210.1016/j.jneuroim.2004.12.015Search in Google Scholar PubMed
[8] Wang Y., et al., T33 a novel peroxisome proliferator-activated receptor gamma/alpha agonist, exerts neuroprotective action via its anti-inflammatory activities, Act. Pharmacol. Sin., 2011, 32(9), 1100-110810.1038/aps.2011.69Search in Google Scholar PubMed PubMed Central
[9] Garrido-Gil, et al., Involvement of PPAR-γ in the Neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson’s disease, Journal of Neuroinflammation, 2012, 9, 3810.1186/1742-2094-9-38Search in Google Scholar PubMed PubMed Central
[10] Xiao J., Leung J.C., et al., Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy, Clin. Immunol., 2009, 132, 266-27610.1016/j.clim.2009.04.004Search in Google Scholar PubMed
[11] Pacher P., Beckman J.S., et al., Nitric oxide and peroxynitrite in health and disease, Physiol. Rev., 2007, 87(1), 315-42410.1152/physrev.00029.2006Search in Google Scholar PubMed PubMed Central
[12] Aloisi F., Immune function of microglia, Glia, 2001, 36(2), 165-17910.1002/glia.1106Search in Google Scholar PubMed
[13] Pearson Q., Beers G.T., et al., Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocr. Rev., 2001, 22(2), 153-18310.1210/er.22.2.153Search in Google Scholar
[14] Chow Y.L., et al., Cardamom from Alpena rafflesiana inhibits inflammatory responses in IFN-gamma/LPS-stimulated BV2 microglia via NF-kappaB signaling pathway, Int. Immunopharmacol, 2012, 12(4), 657-6510.1016/j.intimp.2012.01.009Search in Google Scholar PubMed
© 2015
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
